MetaCap

Tarsus Pharmaceuticals Insider Trades

NASDAQ: TARSHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD

73.01-4.66 (-6.00%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Last 12 months

Purchases
0 · $0
Sales
46 · $15.75M
Shares bought / sold
0 / 219.21K
Net activity
Net selling $15.7 million

Tarsus Pharmaceuticals insider activity

Over the last 12 months, Tarsus Pharmaceuticals insiders reported 62 transactions on SEC Form 4: 0 open-market purchases and 46 sales. Insiders bought $0 and sold $15.7 million worth of stock, for net insider selling of $15.7 million. The largest seller was Azamian Bobak R., with $5.5 million in reported sales.

The most recent filing shows Azamian Bobak R. (President/CEO and Board Chair) selling 10,000 shares at $80.31 on Nov 13, 2026. Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put TARS's ownership changes in context.

Summary generated from market data by MetaCap's automated system. Methodology

TARS insider transactions

Tarsus Pharmaceuticals insider transactions
DateInsiderTypeSharesValueFiling
Nov 13, 2026Azamian Bobak R.President/CEO and Board ChairSale10,000$803.10KForm 4
Sep 15, 2026YARNO WENDY LDirectorOption exercise302—Form 4
Sep 15, 2026PYOTT DAVID E IDirectorOption exercise201—Form 4
Sep 15, 2026LINK WILLIAM J PHDDirectorSale66$5.28KForm 4
Sep 15, 2026LINK WILLIAM J PHDDirectorSale759$59.96KForm 4
Sep 15, 2026LINK WILLIAM J PHDDirectorSale11,675$914.50KForm 4
Sep 15, 2026LINK WILLIAM J PHDDirectorOption exercise201—Form 4
Sep 4, 2026Lin Elizabeth YeuChief Medical OfficerSale1,590$143.10KForm 4
Sep 4, 2026Lin Elizabeth YeuChief Medical OfficerSale1,590$135.15KForm 4
Sep 4, 2026Lin Elizabeth YeuChief Medical OfficerSale5,386$484.74KForm 4
Sep 4, 2026Lin Elizabeth YeuChief Medical OfficerSale5,387$457.89KForm 4
Sep 4, 2026Azamian Bobak R.President/CEO and Board ChairSale2,900$264.68KForm 4
Sep 4, 2026Azamian Bobak R.President/CEO and Board ChairSale7,100$640.92KForm 4
Sep 4, 2026Neervannan SeshadriChief Operating OfficerSale4,564$387.94KForm 4
Sep 2, 2026Azamian Bobak R.President/CEO and Board ChairSale10,000$800.60KForm 4
Sep 2, 2026Lin Elizabeth YeuChief Medical OfficerSale1,590$127.20KForm 4
Sep 2, 2026Lin Elizabeth YeuChief Medical OfficerSale5,387$430.96KForm 4
Sep 1, 2026Lin Elizabeth YeuChief Medical OfficerSale4,601$339.83KForm 4
Jun 17, 2026Azamian Bobak R.President/CEO and Board ChairSale5,418$334.89KForm 4
Jun 17, 2026Azamian Bobak R.President/CEO and Board ChairSale4,582$280.60KForm 4
Jun 16, 2026Farrow Jeffrey SSee RemarksSale14,396$877.44KForm 4
Jun 15, 2026Goodrich KatherineDirectorSale2,954$183.38KForm 4
Jun 15, 2026LINK WILLIAM J PHDDirectorSale1,928$121.35KForm 4
Jun 15, 2026LINK WILLIAM J PHDDirectorSale10,572$655.15KForm 4
Jun 15, 2026Farrow Jeffrey SSee RemarksOption exercise27,881—Form 4
Jun 12, 2026Goldberg Andrew D.DirectorOption exercise2,954—Form 4
Jun 12, 2026YARNO WENDY LDirectorOption exercise2,954—Form 4
Jun 12, 2026LINK WILLIAM J PHDDirectorOption exercise2,954—Form 4
Jun 12, 2026Morrison Scott WDirectorOption exercise2,954—Form 4
Jun 12, 2026Goodrich KatherineDirectorOption exercise2,954—Form 4
Jun 12, 2026CHAUDHURI BHASKARDirectorOption exercise2,954—Form 4
Apr 24, 2026PYOTT DAVID E IDirectorOption exercise1,383—Form 4
Mar 20, 2026Neervannan SeshadriChief Operating OfficerSale2,989$199.52KForm 4
Mar 19, 2026Wahl BryanGeneral CounselSale4,231$283.48KForm 4
Mar 19, 2026Azamian Bobak R.President/CEO and Board ChairSale11,964$801.59KForm 4
Mar 19, 2026Lin Elizabeth YeuChief Medical OfficerSale390$26.13KForm 4
Mar 19, 2026Mottiwala AzizChief Commercial OfficerSale4,440$297.48KForm 4
Mar 19, 2026Farrow Jeffrey SSee RemarksSale2,186$146.46KForm 4
Mar 19, 2026Whitfield Dianne C.Chief Human Resources OfficerSale4,174$279.66KForm 4
Mar 19, 2026Neervannan SeshadriChief Operating OfficerSale4,589$307.46KForm 4
Mar 18, 2026Wahl BryanGeneral CounselSale4,125$283.43KForm 4
Mar 18, 2026Azamian Bobak R.President/CEO and Board ChairSale11,667$801.64KForm 4
Mar 18, 2026Lin Elizabeth YeuChief Medical OfficerSale379$26.04KForm 4
Mar 18, 2026Mottiwala AzizChief Commercial OfficerSale4,330$297.51KForm 4
Mar 18, 2026Farrow Jeffrey SSee RemarksSale2,133$146.56KForm 4
Mar 18, 2026Whitfield Dianne C.Chief Human Resources OfficerSale4,071$279.72KForm 4
Mar 18, 2026Neervannan SeshadriChief Operating OfficerSale3,610$248.04KForm 4
Mar 17, 2026Wahl BryanGeneral CounselSale4,084$283.51KForm 4
Mar 17, 2026Azamian Bobak R.President/CEO and Board ChairSale10,972$761.68KForm 4
Mar 17, 2026Lin Elizabeth YeuChief Medical OfficerSale375$26.03KForm 4
Mar 17, 2026Mottiwala AzizChief Commercial OfficerSale4,286$297.53KForm 4
Mar 17, 2026Farrow Jeffrey SSee RemarksSale2,111$146.55KForm 4
Mar 17, 2026Whitfield Dianne C.Chief Human Resources OfficerSale4,029$279.69KForm 4
Mar 17, 2026Neervannan SeshadriChief Operating OfficerSale3,125$216.94KForm 4
Mar 16, 2026LINK WILLIAM J PHDDirectorSale493$34.39KForm 4
Mar 16, 2026LINK WILLIAM J PHDDirectorSale8,378$578.33KForm 4
Mar 16, 2026LINK WILLIAM J PHDDirectorSale3,629$247.10KForm 4
Mar 15, 2026Farrow Jeffrey SSee RemarksOption exercise13,042—Form 4
Mar 15, 2026Mottiwala AzizChief Commercial OfficerOption exercise26,482—Form 4
Mar 15, 2026Neervannan SeshadriChief Operating OfficerOption exercise26,287—Form 4
Mar 15, 2026Wahl BryanGeneral CounselOption exercise24,236—Form 4
Mar 15, 2026Whitfield Dianne C.Chief Human Resources OfficerOption exercise23,909—Form 4

Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4

Related